Cyteir Therapeutics Inc

NASDAQ CYT

Data sourced from

and

Download Data

Cyteir Therapeutics Inc Days Payable Outstanding (DPO) 5 year CAGR for the year ending December 31, 2022

Cyteir Therapeutics Inc Days Payable Outstanding (DPO) 5 year CAGR is NA for the year ending December 31, 2022. The days payables outstanding ratio measures the average number of days it takes for a company to pay its suppliers. It is calculated by dividing accounts payable by the cost of revenue and then multiplying by 365. This ratio indicates the average payment period for suppliers and reflects the efficiency of managing trade payables. A longer period suggests extended payment terms and potential working capital advantages. CAGR, or the Compound Annual Growth Rate, quantifies the mean annual growth rate of an investment or financial metric over a specified time span, considering the influence of compounding. It is instrumental in determining the true annualized return on an investment.

Cyteir Therapeutics Inc Days Payable Outstanding (DPO) for the year ending December 31, 2022 was 299.43, a -77.99% change year over year.
Cyteir Therapeutics Inc Days Payable Outstanding (DPO) for the year ending December 31, 2021 was 1,360.18, a -22.56% change year over year.
Cyteir Therapeutics Inc Days Payable Outstanding (DPO) for the year ending December 31, 2020 was 1,756.37.

NASDAQ: CYT

Cyteir Therapeutics Inc

CEO	Mr. Joseph S. Zakrzewski
IPO Date	June 18, 2021
Location	United States
Headquarters	128 Spring Street, Lexington, MA, United States, 02421
Employees	46
Sector	Healthcare
Industry	Biotechnology

Description

Cyteir Therapeutics, Inc., a clinical-stage biotechnology company, develops and commercializes the oncology therapeutics. Its lead product CYT-0851, an oral investigational drug that inhibits monocarboxylate transporters that is in Phase I/II clinical trial for monotherapy in solid tumors and hematologic malignancies, as well as for combination therapy in solid tumors and hematologic malignancies. Cyteir Therapeutics, Inc. was incorporated in 2012 and is headquartered in Lexington, Massachusetts.

Key trends